Abstract
Type II Epstein-Barr virus (EBV) associated malignancies such as nasopharyngeal carcinoma and non-Hodgkin's lymphomas consistently express latent membrane 2A (LMP2A) proteins, which have been suggested to be an ideal target for immunotherapy. In previous studies we have demonstrated that using LMP2A protein loaded dendritic cells, the most powerful antigen processing cells in the body can elicit specific and robust anti-tumor cellular immune response in vitro. In this paper, we further investigated the T cell profile of the anti-tumor immune response. We found that LMP2A specific CD4+ and CD8+ T cells could be stimulated by LMP2A protein loaded dendritic cells (DCs). The Th1 type immune response is dominant in the immune response mediated by LMP2A specific CD4+ T cells. The CD8+ cytotoxic T cells can lyse LMP2A bearing cells effectively and specifically. The CD8+ cytotoxic T cells can also secrete high level of intracellular IFN-γ, which indicates these cells are EBV-LMP2A specific cytotoxic T cells. Altogether, our studies proved that LMP2A protein loaded DCs can elicit anti-tumor cellular immune responses efficiently. This study provides a rationale for the DC-based immunotherapy against EBV-LMP2A expressing malignancies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Chen, Y., Sun, H., Liu, G. et al. EBV LMP2A-specific T Cell Immune Responses Elicited by Dendritic Cells Loaded with LMP2A Protein. Cell Mol Immunol 6, 269–276 (2009). https://doi.org/10.1038/cmi.2009.36
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2009.36
Keywords
This article is cited by
-
Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma
Oncogene (2012)
-
Efficient induction of a Her2-specific anti-tumor response by dendritic cells pulsed with a Hsp70L1–Her2341–456 fusion protein
Cellular & Molecular Immunology (2011)